Showing 281-290 of 350 grants

Title Institution Researcher Program Duration Total Award Amount
Determining how NKG2D signaling drives autoimmune diabetes University of Kansas Medical Center Research Institute, Inc. Mary Markiewicz Cures 01-September-2023 to 31-August-2026 $749,980.79
Engineering a novel Treg population to control autoimmune diabetes University of Kansas Medical Center Research Institute, Inc. Mary Markiewicz Cures 01-April-2025 to 31-December-2026 $199,999.62
Defining the target product profile of intra-lymph node depots as a durable antigen-specific immunotherapy for T1D University of Maryland Christopher Jewell Cures 01-April-2026 to 31-March-2029 $1,199,997.36
A Cure for Type 1 Diabetes University of Massachusetts Medical School David Harlan Cures 01-October-2025 to 30-September-2029 $16,000,000.00
In vivo interactions and trafficking of islet antigen-specific human effector T cells and Tregs University of Massachusetts Medical School Michael Brehm Cures 01-November-2024 to 31-October-2027 $825,000.00
Interrogation of FBR immunity using novel humanized mice University of Massachusetts Medical School Michael Brehm Cures 01-October-2026 to 30-September-2027 $300,000.00
Artificial Intelligence-driven redesign of beta cell regulatory logic for resilience to inflammation University of Massachusetts Medical School Rene Maehr Cures 01-April-2026 to 31-March-2027 $199,999.88
Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement University of Miami Alice Tomei Cures 01-February-2024 to 31-January-2027 $824,892.00
Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity University of Miami Dhanashree Surve Cures 01-March-2026 to 28-February-2029 $274,010.00
The KQ1 serum study: amendment & extension University of Miami Dirk Homann Cures 01-April-2025 to 31-October-2027 $1,723,254.07